1. Introduction {#s0005}
===============

In phenylketonuria (PKU) there is a suggestion that overweight and obesity is 'equivalent to' or more common than in the general population [@bb0005], [@bb0010], [@bb0015]. Low phenylalanine and high energy foods are encouraged in order to promote anabolism and to prevent protein insufficiency [@bb0020]. There is some speculation that this approach may promote obesity [@bb0005] but it requires further study. There are no evidence-based studies to indicate if overweight or obesity is related to the disorder itself, the low phenylalanine diet or patient lifestyle behaviour [@bb0020].

Considering that in PKU there are a lack of studies comparing prevalence of overweight and obesity between countries, the aim of this cross sectional study was to evaluate prevalence data from 8 different treatment centres in Europe and Turkey.

2. Subjects and methods {#s0020}
=======================

This was a retrospective, cross-sectional study comparing data on BMI (collected between 2005 and 2014), using a predefined set of questions for treated patients with PKU from one Turkish and 7 European centres. The centres providing data were from Belgium (Brussels), Denmark (Copenhagen), Germany (Munich), The Netherlands (Groningen), Portugal (Porto), Spain (Madrid), Turkey (Ankara) and the United Kingdom (UK) (Birmingham). One hundred and sixty four adults from 6 centres (Ankara, Brussels, Groningen, Madrid, Munich and Porto) and 783 children aged \< 19 years from 7 centres (Ankara, Birmingham, Brussels, Copenhagen, Groningen, Madrid and Porto) were included ([Table 1](#t0005){ref-type="table"}). This project was considered by the NHS Health Research Authority decision tool ([www.hra-decisiontools.org.uk](http://www.hra-decisiontools.org.uk){#ir0020}) as non-research and as such did not require ethical approval.

Eligible patients with PKU were diagnosed by newborn screening, on dietary treatment, with or without BH~4~ (tetrahydrobiopterin, sapropterin dihydrochloride) therapy and with or without large neutral amino-acid (LNAA) supplements. Exclusion criteria included patients not on dietary treatment, on pre-conception diet, pregnant or late treated patients.

The age, gender, height and body weight for all patients \< 19 years of age were collected in routine hospital clinics. The WHO Anthro and AnthroPlus programmes, software programmes provided by the WHO, calculated BMI percentile and z-score. Overweight classification was as follows: for patients \< 5 years: BMI z score ≥ 2 and \< 3 SD, for patients 5--18 years: BMI z score ≥ 1 and \< 2 SD. Obesity classification was for patients \< 5 years: BMI z score ≥ 3 and for patients 5--18 years: BMI z score ≥ 2 SD [@bb0025], [@bb0030], [@bb0035], [@bb0040]. Percentages of overweight/obesity and obesity were calculated respectively from BMI z scores and compared with local general population ranges [@bb0045].

For adult PKU patients (≥ 19 years), BMI was calculated as weight (kg) / height (m^2^), and classified into BMI categories according to the WHO classification; overweight (≥ 25.0--29.9 kg/m^2^) and obesity (≥ 30.0 kg/m^2^) [@bb0050]. Subsequently, percentages of overweight/obesity and obesity were calculated.

3. Results {#s0010}
==========

3.1. Adults ([Table 2](#t0010){ref-type="table"}) {#s0025}
-------------------------------------------------

The majority of centres (83%; n = 5 of 6) had less overweight in patients with PKU, with obesity rates being the same or less in 4 of 6 (67%) centres than the respective general populations. In 5 of 6 (83%) centres there was a higher rate of obesity in females than males and in 4 centres this was higher than the respective general population. In contrast, only in Groningen and Munich were there more obese males with PKU than the general population.

3.2. Children ([Table 3](#t0015){ref-type="table"}) {#s0030}
---------------------------------------------------

In boys in Ankara, Birmingham, and Porto there were less overweight and obesity than the respective ranges in the general populations. Although boys in Brussels, Copenhagen, Groningen and older boys in Madrid had a higher rate of combined overweight/obesity, they had a lower rate of obesity only than the general population ranges. In girls there was a higher rate of combined overweight/obesity in Brussels, and Copenhagen and more obesity only in Ankara, Birmingham, Copenhagen and Groningen than the general population ranges. In Brussels, Madrid and Porto girls, there was less obesity.

4. Discussion {#s0015}
=============

This is the first multi-centre European and Turkish cross sectional study in 947 patients with PKU to report the prevalence of overweight and obesity. In adults, the majority of centres reported similar or lower rates of obesity to their general populations [@bb0050]. In children although there is less or similar rates of obesity in boys to the local general population, in girls there is a trend for a higher rate of obesity, as previously reported [@bb0010], [@bb0015]. It is unknown if body composition studies would reflect the same trend and this deserves further study [@bb0055]. In parallel to the respective general populations [@bb0045], [@bb0050], the percentage of overweight increased with age. In order to avoid using different criteria to assess defining overweight and obesity and to facilitate comparisons between different countries and populations, in this survey the WHO BMI z scores were used to assess overweight and obesity in children and the body mass index (weight / height^2^) for the adult population.

Overall, despite similar PKU treatment approaches, the prevalence of overweight and obesity did vary between treatment centres, and it commonly followed respective national trends. Blood phenylalanine control of PKU patients from this group of PKU centres, except for Porto, has been published previously [@bb0060]. Energy and protein intakes were not reported in this audit but commonly overweight and obesity result from an eclectic combination of genetic, environmental, dietary and social factors. Although in non-PKU individuals, associated non-dietary factors include maternal overweight, high birth weight and smoking in pregnancy, there is little data reported in PKU for any of these factors [@bb0020].

In conclusion, although the prevalence of overweight and obesity varied widely between countries it was mainly similar or even less than the respective general populations for adults and boys. Women and girls with PKU appear particularly vulnerable to excess weight gain and it is important that female weight gain is targeted and closely monitored from an early age with individual strategies introduced to avoid and control excess weight gain. More research is needed to identify the main risk factors associated with overweight and obesity in females with PKU. In general, there is a need to better understand the food patterns, energy and nutrient intakes and the physical activity of patients with PKU.
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###### 

Number of patients and patient demographics from 8 centres across Europe and Turkey all diagnosed by newborn screening.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  PKU centres                      Total   Treatment                                              Children (\< 19 years)                             Adults
  -------------------------------- ------- ------------------------------------------------------ -------------------------------------------------- --------------------------------------------
  Ankara\                          411     Low phe diet n = 411                                   n = 397\                                           14\
  Data collected in 2008\                                                                         (219 boys, 178 girls)\                             (4 males, 10 females)\
  All patients born ≥ 1982                                                                        Age range: 1.7 months--17.9 years                  Median age 22.9 years (range 19--26 years)

  Birmingham\                      85      BH4 + low phe diet n = 7\                              n = 85\                                            n/a
  Data collected in 2014\                  Low phe diet\                                          (46 boys, 39 girls)\                               
  All children born ≥ 1996                 n = 78                                                 Age range: 1--17 years                             

  Brussels\                        62      BH4 + low phe diet n = 12\                             n = 40\                                            22\
  Data collected in 2012                   Low phe diet n = 50                                    (20 boys, 20 girls)\                               (7 males, 15 females)\
                                                                                                  Age range: 1 year, 3 months--17 years, 11 months   Median age 19 years, 7 months

  Copenhagen\                      85      Low phe diet n = 85                                    n = 85\                                            n/a
  Data collected in 2011\                                                                         (28 boys, 57 girls)\                               
  All children born ≥ 1995                                                                        Age range: 6--15 years                             

  Groningen\                       78      Low phe diet n = 78[a](#tf0005){ref-type="table-fn"}   n = 45\                                            33\
  Data collected in 2011                                                                          (23 boys, 22 girls)                                (16 males, 17 females)

  Madrid\                          83      BH4 only n = 11\                                       n = 49\                                            34\
  Data collected in 2012\                  BH4 + low phe diet n = 8\                              (21 males, 28 females)\                            (14 males, 20 females)
  All patients born ≥ 1979                 Low phe diet n = 64                                    Age range: 1 year--\< 19 years                     

  Munich\                          32      Low phe diet n = 32                                    n/a                                                32\
  Data collected in 2005--2006\                                                                                                                      (12 males, 20 females)
  All patients born ≥ 1967                                                                                                                           

  Porto\                           111     Low phe diet n = 111                                   n = 82\                                            29\
  Data collected in 2010--2011.\                                                                  (51 boys, 31 girls)\                               (10 males, 19 females)
  All patients born ≥ 1982                                                                        Age range: 1 year--\< 19 years                     

  Totals                           947     947                                                    783                                                164
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

25 patients started BH4 for only a short time pre-assessment of overweight/obesity.

###### 

Overweight and obesity percentages in adults with PKU compared with national general population (OECD i library, updated 2013) and gender differences for 6 centres.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  PKU centres   PKU population % overweight/obese\   General population % overweight/obese\   PKU population % obesity\   General population % obesity\   Gender differences                 
                BMI ≥ 25.0 kg/m^2^                   BMI ≥ 25.0 kg/m^2^                       BMI ≥ 30 kg/m^2^            BMI ≥ 30 kg/m^2^                                                   
  ------------- ------------------------------------ ---------------------------------------- --------------------------- ------------------------------- -------------------- ------ ------ ------
  Ankara        28.4                                 33.0                                     14.3                        16.9                            25.0                 20.0   0      20.0

  Brussels      27.3                                 33.1                                     4.5                         13.8                            14.3                 33.3   0      6.7

  Groningen     15.2                                 36.8                                     24.2                        11.4                            19.0                 24.0   19.0   18.0

  Madrid        42.0                                 37.6                                     16.0                        16.0                            42.0                 40.0   7.0    25.0

  Munich        34.4                                 36.7                                     18.7                        14.7                            33.3                 35.0   16.7   20

  Porto         24.1                                 36.2                                     10.3                        15.4                            30.0                 21.1   10.0   10.5
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Overweight and obesity percentages in children with PKU compared with national general population (Ng et al. [@bb0045]) for 7 centres.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  PKU centres   Age of children with PKU        \% overweight (includes overweight and obesity) in PKU   \% obesity in PKU   Boys (PKU)   Girls (PKU)   Data from global, regional, and national prevalence of overweight and obesity in children and adults during 1980--2013: Ng et al. [@bb0045]                                                                     
  ------------- ------------------------------- -------------------------------------------------------- ------------------- ------------ ------------- --------------------------------------------------------------------------------------------------------------------------------------------- ------- ------------------- ----------------- ------------------- ------------------
  Ankara        1.7--17.9 years\                19.8%                                                    9.8%                18.7%        7.8%          21.3%                                                                                                                                         12.3%   20.4 (17.5--23.6)   7.1 (5.7--8.7)    19.8 (16.6--23)     5.7 (4.5--7)
                median age 4.6 years\                                                                                                                                                                                                                                                                                                                                   
                (n = 397)                                                                                                                                                                                                                                                                                                                                               

  Birmingham    1--3 years (n = 12)\            8%\                                                      0%\                 21.7%        6.5%          31%                                                                                                                                           10.3%   26.1 (23.8--28.5)   7.4 (6.5--8.5)    29.2 (26.8--31.9)   8.1 (7.0--9.3)
                4--11 years (n = 45)\           20%\                                                     8.9%\                                                                                                                                                                                                                                                          
                ≥ 12 years--18 years (n = 28)   43%                                                      11%                                                                                                                                                                                                                                                            

  Brussels      1--8 years\                     32.5%                                                    2.5%                40%          5%            25%                                                                                                                                           0%      20.5 (17.7--23.6)   4.6 (3.7--5.5)    18.8 (16.0--21.8)   4.2 (3.3--5.1)
                median age 7.1 years                                                                                                                                                                                                                                                                                                                                    

  Copenhagen    6--10 years (n = 49)\           29%\                                                     6%\                 33%\         7%\           26%\                                                                                                                                          9%\     19.7 (16.8--23.1)   8.7 (7.1--10.7)   19.4 (15.8--23.2)   5.9 (4.7--7.5)
                11--15 years (n = 36)           30%                                                      8%                  27%          0%            35%                                                                                                                                           13%                                                               

  Groningen     4--10 years (n = 28)\           25%\                                                     4%\                 45%          0%            17%                                                                                                                                           17%     18.3 (15.7--21.3)   4.1 (3.4--5)      16.1 (13.4--18.9)   3.8 (3--4.7)
                11--18 years (n = 17)           45%                                                      17%                                                                                                                                                                                                                                                            

  Madrid        ≤ 10 years (n = 30)\            3%\                                                      3%\                 0%\          6%\           0%\                                                                                                                                           0%\     27.6 (23.9--31.2)   8.4 (6.7--10.2)   23.8 (20.2--27.4)   7.6 (6.0--9.3)
                10--18 years (n = 19)           29%                                                      0%                  37%          0%            22%                                                                                                                                           0%                                                                

  Porto         \< 5 years (n = 9)\             0%\                                                      0%\                 0%\          0%\           0%\                                                                                                                                           0%\     28.7 (24.9--31.8)   8.9 (7.4--10.9)   27.1 (23.4--31.4)   10.6 (8.5--12.9)
                5--\< 19 years (n = 73)         26%                                                      8.2%                22.7%        9.1%          31%                                                                                                                                           6.9%                                                              
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
